Pharmaceutical

Jeito Capital secures over $1.2bn for new biopharma inv...

The milestone increases Jeito’s assets under management to €1.6bn, following the...

OPPI collaborates with NIPER Rae Bareli to advance rese...

The Organisation of Pharmaceutical Producers of India (OPPI) has announced a st...

Glenmark receives US FDA approval for Progesterone Vagi...

Glenmark Pharmaceuticals has received final approval from the United States Foo...

Lupin receives ANDA approval for Dapagliflozin, Metform...

Global pharma major Lupin Limited (Lupin) today announced that it has received ...

Merck expands Bengaluru facility to boost global supply...

Merck, a leading science and technology company, announced the expansion of its...

Halozyme and Vertex sign deal for Hypercon technology

Vertex has licensed the technology for use in up to three drug targets, as part ...

RoosterBio and MineBio team up to expand MSC solutions ...

MineBio will supply RoosterBio’s complete platform of products, having already o...

Lupin receives US FDA approval for Dapagliflozin tablets

Approval confirms bioequivalence to Farxiga for approved indications The post ...

Biocon launches Bosaya and Aukelso in the United States

Denosumab biosimilars made available through specialty pharmacies and healthcar...

Inventia enters the U.S. market with FDA approved Dapag...

Approval grants eligibility for 180-day shared generic drug exclusivity The pos...

Neurocrine to acquire Soleno in $2.9bn transaction

The transaction will expand Neurocrine’s portfolio in endocrinology and rare dis...

Apnimed obtains up to $150m in funds for commercial lau...

The funding will be used for commercial readiness and the potential US launch of...

Alembic Pharmaceuticals secures USFDA approval for Dapa...

Approval grants eligibility for 180-day shared generic drug exclusivity The pos...

CuraTeQ Biologics reports Phase 3 results for BP11 bios...

Study meets primary endpoints in chronic spontaneous urticaria across Europe an...

Lupin receives Great Place To Work certification across...

Recognition based on study covering subsidiaries and employee participation The...

Bayer revises access model for Eylea 2mg in India to ex...

Company aims to lower upfront cost to support early treatment initiation for re...